Company Filing History:
6 out of 46 
5 out of 5 
2 out of 60 
Years Active: 2017-2025
Title: The Innovative Contributions of David Flyer
Introduction
David Flyer is a notable inventor based in Olney, MD (US), recognized for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, Flyer has made strides in developing methods and compositions that address bacterial infections and neutralize toxins.
Latest Patents
Among his latest patents is the invention of isolated polypeptides of the toxin A and toxin B proteins. This invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides that comprise the receptor binding domains of toxin A and toxin B, as detailed in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. These polypeptides are designed to neutralize the toxic effects of toxin A and/or toxin B. Additionally, Flyer has developed methods and compositions for inducing immune responses against bacterial infections. These compositions include vaccines containing multimeric polypeptides that induce effective immune responses, thereby treating or preventing infections.
Career Highlights
Flyer has worked with prominent companies in the biotechnology sector, including Valneva Austria GmbH and Valneva USA, Inc. His work in these organizations has contributed to advancements in vaccine development and therapeutic solutions for bacterial infections.
Collaborations
Flyer has collaborated with esteemed colleagues such as Jing-Hui Tian and Gregory M Glenn, further enhancing the impact of his research and innovations in the field.
Conclusion
David Flyer stands out as an influential inventor whose work has the potential to significantly improve public health through innovative solutions to bacterial infections and toxin neutralization. His contributions continue to shape the landscape of biotechnology and medical research.